
Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …

Scientists from Janssen and The Scripps Research Institute (TSRI) have found a way to induce antibodies to fight a wide …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

